Regeneron stock heads into the open after a 1.7 percent gain
Published on 09/22/2026 at 03:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Regeneron stock closed around USD 797.99 on the Nasdaq on September 21, 2026, representing a gain of approximately 1.7% compared with the prior close near USD 784.85 per Nasdaq data. The advance left the shares above the prior session level while the Dow Jones Industrial Average also climbed about 0.7% on September 21, 2026.
September 21, 2026 in numbers
Regeneron Pharmaceuticals Inc. (ISIN US75886F1075, Nasdaq: REGN) saw its shares trade around USD 797.99 on September 21, 2026 on the Nasdaq, up roughly 1.67% or USD 13.14 from the previous close of USD 784.85 according to a market wrap from Ad-hoc-news. The same overview cited intraday readings around USD 795.04, indicating a trading range with the close near the upper end for the session on the primary US venue. In the broader market, the Dow Jones Industrial Average rose about 0.71% to around 52,049.72 points on September 21, 2026, highlighting that Regeneron slightly outpaced the blue-chip benchmark on the day, as reported by Capital Futures.
The session move followed legal developments that reduced a key overhang for shareholders. A report from Law360 on September 21, 2026 detailed that Regeneron Pharmaceuticals Inc. and several executives prevailed in a proposed securities class action, with a judge ruling that investors could not rely on a separate False Claims Act case to support allegations about earlier share losses. As Ad-hoc-news noted, the easing of legal risk, together with the company’s dividend profile, supported buying interest in the shares during the session.
Legal backdrop and market cues today
Today, September 22, 2026, Regeneron enters the new session with the prior day’s legal ruling still shaping sentiment after the court rejected the investors’ attempt to use the False Claims Act case to bolster their securities claims, as outlined by Law360. Broader market conditions are also in focus ahead of the open after US equity benchmarks logged their best day since early August on September 21, 2026, with stock futures trading near flat levels into the new session according to a live markets update from CNBC. Against that backdrop, investors watch how Regeneron trades today following its recent outperformance of the Dow Jones index and the latest step in clearing litigation-related uncertainty.
